Korean J Anesthesiol. 2013 Jan;64(1):47-53. doi: 10.4097/kjae.2013.64.1.47. Epub 2013 Jan 21.
The effects of an insulin-glucose-potassium (IGK) pretreatment on the bupivacaine cardiotoxicity.
Korean journal of anesthesiology
Jin-Tae Kim, Sol-Mon Yang, Kook Hyun Lee
Affiliations
Affiliations
- Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea.
PMID: 23372886
PMCID: PMC3558649 DOI: 10.4097/kjae.2013.64.1.47
Abstract
BACKGROUND: The purpose of this study is to evaluate the effect of an IGK pretreatment on the cardiotoxicity of bupivacaine.
METHODS: Twenty-one anesthetized mongrel dogs were randomly divided into the following three groups: the control group (CG, n = 7), the treatment group (TG, n = 7) and the pretreatment group (PTG, n = 7). For the 30 min of pretreatment period, CG and TG received normal saline, while PTG received an IV bolus of insulin 2 U/kg, followed by an IGK infusion (2 U/kg/hr of insulin, 0.5-1.5 g/kg/hr of glucose, 1-2 mEq/kg/hr of KCl). The bupivacaine infusion was started at the rate of 0.5 mg/kg/min in all groups after the pretreatment period. CG received normal saline only. In TG, insulin (2 U/kg) was injected simultaneously with bupivacaine infusion, followed by the IGK infusion as with PTG. The hemodynamic variables and the time duration to reach the mean arterial pressure (MAP) of 60 mmHg were compared.
RESULTS: The bupivacaine infusion decreased the cardiac index, MAP, and heart rate in all three groups. Although insulin concentration was higher in TG than in PTG during bupivacaine infusion, the hemodynamic variables in PTG decreased at the slowest rate. The time taken to reach MAP of 60 mmHg in PTG, TG, and CG was 51.4 ± 8.5, 36.4 ± 9.6, and 27.1 ± 8.7 min, respectively (P < 0.05).
CONCLUSIONS: IGK delays the bupivacaine-induced cardiac depression. However, a pretreatment with IGK is more effective in delaying the bupivacaine-induced hypotension than simultaneous administration, regardless of insulin concentration.
Keywords: Bupivacaine; Cardiotoxicity; Dog; Insulin
References
- J Cardiovasc Pharmacol. 1987 Sep;10(3):259-67 - PubMed
- Anesth Analg. 2000 Nov;91(5):1096-102 - PubMed
- J Pharmacol Exp Ther. 1990 Dec;255(3):1038-46 - PubMed
- Anesth Analg. 1986 Jun;65(6):551-9 - PubMed
- Pflugers Arch. 1992 Dec;422(3):267-72 - PubMed
- Ann Thorac Surg. 2003 Feb;75(2):S721-8 - PubMed
- Curr Opin Clin Nutr Metab Care. 2006 Mar;9(2):131-9 - PubMed
- Anesth Analg. 1992 May;74(5):698-702 - PubMed
- Anesth Analg. 1994 Feb;78(2):335-9 - PubMed
- Anesthesiology. 1985 Apr;62(4):396-405 - PubMed
- Am J Physiol. 1998 Apr;274(4):E642-50 - PubMed
- Circulation. 1997 Dec 2;96(11):4104-13 - PubMed
- Am J Cardiol. 1977 Sep;40(3):421-8 - PubMed
- J Biol Chem. 1990 May 15;265(14):7837-42 - PubMed
- Circulation. 2006 Jul 4;114(1 Suppl):I239-44 - PubMed
- Circulation. 1997 Aug 19;96(4):1152-6 - PubMed
- Am J Cardiol. 1976 Sep;38(3):310-21 - PubMed
- Biochem J. 1990 Oct 1;271(1):269-72 - PubMed
- Anesth Analg. 1989 Dec;69(6):732-5 - PubMed
- Anesthesiology. 2002 Nov;97(5):1168-77 - PubMed
- Metabolism. 1992 Jul;41(7):711-6 - PubMed
- Eur J Anaesthesiol. 2007 Apr;24(4):340-6 - PubMed
- Am J Cardiol. 1979 Apr;43(4):801-9 - PubMed
- Anesth Analg. 2004 Sep;99(3):728-733 - PubMed
- Anesthesiology. 2004 Oct;101(4):888-94 - PubMed
- Anesth Analg. 2001 Apr;92(4):1075-6 - PubMed
- Cardiovasc Surg. 1999 Oct;7(6):645-50 - PubMed
- J Mol Cell Cardiol. 1998 Oct;30(10):2025-35 - PubMed
- Circ Res. 1970 Nov;27(5):835-49 - PubMed
- Anesthesiology. 1979 Oct;51(4):285-7 - PubMed
Publication Types